Saiba X AG develops vaccines and virus-like particle technologies for use against chronic and infectious diseases. The company also provides consulting, licensing and development services for vaccine projects.
AI-generated
Offering
Products & services
Industry:Pharmaceutical Industry
✓ Offered4
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Advice on translational immunology projects, opportunities, options and strategies for vaccine development and related initiatives.
Licensing proprietary technology
Licensing of proprietary vaccine technology and intellectual property rights, tailored to the specific application.
Vaccine development
Support for vaccine projects from planning through preclinical proof-of-principle studies to scale-up and GMP-compliant manufacturing.
VLP-based conjugate vaccines
Development of virally shaped nanoparticles as a scaffold for tailor-made vaccines and induction of long-lasting antibody responses against target antigens.
Comparisons
Saiba X AG in comparison
Soon
Industry comparisons are coming soon
We're preparing industry comparisons that rank Saiba X AG by reviews, experience and specialisations.
Knowledge
No knowledge articles yet
Once Saiba X AG has claimed this profile, we'll publish editorial articles and case studies here together.